Limpa 5/25 mg Tablet is a prescription medication developed by Aristopharma Ltd., combining two antidiabetic agents: Empagliflozin (25 mg) and Linagliptin (5 mg). This combination is designed to enhance blood sugar control in adults with type 2 diabetes mellitus, particularly when diet and exercise alone are insufficient